Breast cancer: Where we were and how far we’ve come

Liz Meszaros, MDLinx

San Antonio Breast Cancer Symposium 2017

San Antonio, Texas, United States | December 05-09, 2017


Over the past few decades, great progress has been made in the field of breast cancer, according to Tatiana Prowell, MD, breast cancer scientific liaison, FDA Oncology Center of Excellence, and assistant professor of oncology, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University.


“When you take a long view, you take sort of a 30,000-foot view, you realize that all of these little incremental gains that we make, that in the moment, may not feel that significant [that] over a decade, have completely transformed a disease from what it once was to what it will be in the future,” said Dr. Prowell.

She sent out a message to patients, imploring them to enroll in clinical trials so that this work can continue to go forward. Her message for investigators was, “Keep going. What you are doing matters, it counts.”

“My message to everyone in every sector is ‘keep it up.’ They’re really doing a tremendous job and it’s really gratifying to see,” Dr. Prowell concluded.